Grunenthal Logo

External Link

You are now leaving the Grünenthal website. You will be re-directed to an external website. Grünenthal accepts no responsibility for the content of other websites.

Title
Description
Trial IDKF7013-01
Compound
Trials sponsorGrünenthal GmbH
Trial phase2
Brief titleEfficacy and safety of intravenous neridronic acid in CRPS-I
IndicationPain associated with CRPS-I
UTNU1111-1151-2181
CTG IDNCT02402530
CTIS ID (former EudraCT)2014-001915-37
Trial statusCompleted
FPIApril 1, 2015
LPONovember 2, 2016
CountriesGermany, Hungary, Italy, Latvia, Netherlands, Poland, Portugal, Romania, Spain, Austria, Croatia, Slovakia, United Kingdom, Netherlands
GenderAll
Age>= 18 years of age
ResultsYes
Pubmed
Documentskf7013-01-lay-summary-english
kf7013-01-lay-summary-german